Els Beirnaert

Els Beirnaert, Ph.D., brings along 18 years of experience in drug development, venture and business development. Previously she was one of the start-up pioneers of Ablynx leading multidisciplinary project teams and translating drug development projects from discovery to pre-clinical development to clinical development (phase 1 and phase 2a). She was Head of New Ventures at VIB responsible for the establishment of start-up/spin-out companies in life sciences. She served on the board of directors of Confo Therapeutics, Q-Biologicals, and Multiplicom. Dr. Beirnaert obtained a Master in Biotechnology at the University of Ghent and a Ph.D. in Biochemistry at the University of Antwerp.